Protein expression
Gene: 
MAGEC2 (official gene symbol)
Other symbol: 
MAGEC2
CT family: 
CT10 
   CT identifier: 
CT10
 
Aliases from NCBI:
 CT10 , HCA587 , MGC13377 
Published data of protein expression in normal tissues
 Show
Published data of protein expression in neoplasias
 Hematologic malignacies Show
                  
                  
                    | Tumor Subtype | Sample type | Frequency | Methodology | PMID | 
                    
                    
 | Myeloma 
 |  | 10/10 (100%) | Western blot | 19190130 | 
 | Myeloma 
 | Bone marrow | 13/24 (54%) | IHC | 20621094 | 
 | Myeloma 
 | Osteolytic lesions | 57/105 (54%) | IHC | 
 | Light-chain amyloidosis (AL amyloidosis) 
 |  | 3/38 (8%) | IHC | 22983433 | 
Brain cancer Show
                  
                  
                    | Tumor Subtype | Sample type | Frequency | Methodology | PMID | 
                    
                    
 | Medulloblastomas 
 |  | 1/25 (4%) | IHC mAb CT10.5 | 18426187 | 
Breast cancer Show
                  
                  
                    | Tumor Subtype | Sample type | Frequency | Methodology | PMID | 
                    
                    
 | Invasive ductal carcinoma 
 | ER-positive tumors | 8/189 (4%) | IHC | 21437249 | 
 | Invasive ductal carcinoma 
 | ER-negative tumors | 31/265 (12%) | IHC | 
 | Invasive ductal carcinoma 
 | ER/PR/HER2 triple-negative tumors | 23/225 (10%) | IHC | 
 | Infiltrating ductal breast carcinoma 
 |  | 40/120 (33%) | IHC | 23315387 | 
Hepatobiliary cancer Show
                  
                  
                    | Tumor Subtype | Sample type | Frequency | Methodology | PMID | 
                    
                    
 | Hepatocellular carcinoma 
 |  | 26/70 (37%) | IHC pAb TC1 | 12920247 | 
 | Cholangiocarcinoma 
 |  | 0/50 (0%) | IHC | 18942708 | 
 | Gallbladder carcinoma 
 |  | 4/32 (13%) | IHC | 
 | Hepatocellular carcinoma 
 |  | 50/146 (34%) | IHC | 
Melanocytic lesion Show
                  
                  
                    | Tumor Subtype | Sample type | Frequency | Methodology | PMID | 
                    
                    
 | Melanoma 
 | Metastatic tumor | 65/163 (40%) | Tissue microarray (IHC) | 21738656 | 
 | Melanoma 
 | Primary tumor | 17/51 (33%) | Tissue microarray (IHC) | 
Prostate cancer Show
                  
                  
                    | Tumor Subtype | Sample type | Frequency | Methodology | PMID | 
                    
                    
 | Adenocarcinoma 
 | Metastatic tumor | 7/43 (16%) | IHC | 21754986 | 
 | Adenocarcinoma 
 | Primary tumor | 11/341 (3%) | IHC | 
 | Benign prostate hyperplasia 
 |  | 0/44 (0%) | IHC | 
Testicular cancer Show
                  
                  
                    | Tumor Subtype | Sample type | Frequency | Methodology | PMID | 
                    
                    
 | Embryonal carcinoma 
 |  | 0/89 (0%) | Tissue microarray | 21780320 | 
 | Seminoma 
 |  | 238/254 (94%) | Tissue microarray | 
 | Seminona (classical) 
 |  | 62/73 (85%) | IHC | 22016418 | 
Published data of protein expression in Cell Lines
 Show
            
              
               | Origin tissue | Cell Line ID | Frequency | Methodology | PMID | 
           
           
| Melanoma |  | 14/68 (17%) | Tissue microarray (IHC) | 21738656 | 
| Myeloma | U266 |  | Western blot | 19190130 |